The evolution of portal hypertension surgery: lessons from 1000 operations and 50 Years' experience.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 11115336)

Published in Arch Surg on December 01, 2000

Authors

H Orozco1, M A Mercado

Author Affiliations

1: Surgical Division, Instituto Nacional de la Nutrición, "Salvador Zubirán," Vasco de Quiroga 15, Tlalpan, DF 14000, Mexico. hozsubcir@quetzal.nnsz.mx

Articles by these authors

Selective shunts for portal hypertension: current role of a 21-year experience. Liver Transpl Surg (1997) 1.45

Long-term evolution of asymptomatic cholelithiasis diagnosed during abdominal operations for variceal bleeding in patients with cirrhosis. Am J Surg (1994) 1.40

Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study. Br J Surg (1991) 1.27

Surgical management of extrahepatic portal hypertension and variceal bleeding. World J Surg (1994) 1.03

The Sugiura procedure for patients with hemorrhagic portal hypertension secondary to extrahepatic portal vein thrombosis. Surg Gynecol Obstet (1991) 0.99

Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma. Eur J Surg (1998) 0.97

Cytokine gene expression in cirrhotic and non-cirrhotic human liver. J Hepatol (1996) 0.96

A comparative study of the elective treatment of variceal hemorrhage with beta-blockers, transendoscopic sclerotherapy, and surgery: a prospective, controlled, and randomized trial during 10 years. Ann Surg (2000) 0.90

Evidence for Ca(2+)-permeable AMPA receptors in the olfactory bulb. Am J Physiol Cell Physiol (2005) 0.84

Elective treatment of bleeding varices with the Sugiura operation over 10 years. Am J Surg (1992) 0.83

Is splenectomy necessary in devascularization procedures for treatment of bleeding portal hypertension? Arch Surg (1998) 0.82

Survival and quality of life after portal blood flow preserving procedures in patients with portal hypertension and liver cirrhosis. Am J Surg (1994) 0.81

Sugiura procedure outside Japan. The Mexican experience. Am J Surg (1986) 0.81

Evaluation and management of the persistent/recurrent varicocele. Urology (2011) 0.79

Role of the distal splenorenal shunt in management of variceal bleeding in Latin America. Am J Surg (1990) 0.78

Ten years of selective shunts for hemorrhagic portal hypertension. Surgery (1988) 0.78

Improved results with selective distal splenorenal shunt in a highly selected patient population. A prospective study. Ann Surg (1989) 0.77

Hepatic chemoinfusion of 5-FU in metastasis of gastrointestinal cancer and advanced primary hepatocellular carcinoma. Eur J Surg Oncol (1992) 0.77

[Evaluation of 20 years of experience and quality of life in patients surgically treated for liver cystic disease]. Rev Gastroenterol Mex (2002) 0.77

A comparative clinical study of idiopathic portal hypertension, extrahepatic portal vein thrombosis, and cirrhosis. J Clin Gastroenterol (1994) 0.77

Surgery in Mexico. Arch Surg (2000) 0.76

Injection sclerotherapy in patients with extrahepatic portal venous obstruction. Ann Surg (1995) 0.75

[The Sugiura operation. Experience at the Instituto Nacional de la Nutrición Salvador Zubirán]. Rev Invest Clin (1986) 0.75

[Selective portal-systemic shunts for bleeding portal hypertension]. Rev Invest Clin (1990) 0.75

Intermittent changes in portal venous flow in relation with spleno-pancreatic collaterals--"the pancreatic siphon"--after a selective shunt in a patient with idiopathic portal hypertension: case report. Surgery (1992) 0.75

New technique for veno-venous bypass in a canine liver transplant model. Transplant Proc (1992) 0.75

[Open cholecystectomy in cirrhotic patients. Experience at the Salvador Zubirán National Institute of Nutrition]. Rev Gastroenterol Mex (1997) 0.75

Long-term endoscopic injection sclerotherapy of bleeding esophageal varices. A prospective analysis of results by endoscopy, manometry and 24-h pH-monitoring. Surg Endosc (1989) 0.75

[Umbilical and inguinal hernioplasty in cirrhotic patients]. Rev Invest Clin (1995) 0.75

Colorectal variceal bleeding in patients with extrahepatic portal vein thrombosis and idiopathic portal hypertension. J Clin Gastroenterol (1992) 0.75

[Postoperative handling in biliodigestive derivation by iatrogenic bile duct injury]. Rev Gastroenterol Mex (2008) 0.75

[Primary cancer of the liver]. Rev Gastroenterol Mex (1998) 0.75

Partial hepatectomy for Caroli's syndrome. Report of two patients with long-term follow-up. Hepatogastroenterology (1991) 0.75

[Adenocarcinoma in situ and adenocarcinoid of the esophagus originating in Barrett's epithelium. Report of a case]. Rev Invest Clin (1987) 0.75

[Abnormalities of the esophageal hiatus in Sugiura's operation]. Rev Invest Clin (1985) 0.75

Conservative and semi-invasive modalities for treating bleeding esophageal varices. Hepatogastroenterology (1990) 0.75

[Laparoscopic cholecystectomy. First year experience at the Salvador Zubirán National Institute of Nutrition]. Rev Invest Clin (1993) 0.75

Comparison of outcomes and complications for open and laparoscopic cholecystectomy in Mexico. J Laparoendosc Surg (1995) 0.75

Analysis of a prospective series of 100 mesocaval interposition shunts for bleeding portal hypertension. Hepatogastroenterology (1990) 0.75

[Surgical treatment of hemorrhagic portal hypertension with selective portosystemic derivations (10 years' experience at the Salvador Zubirán National Institute of Nutrition)]. Rev Invest Clin (1986) 0.75

Selective splenocaval shunt for bleeding portal hypertension: fifteen-year evaluation period. Surgery (1993) 0.75

Surgery in elderly patients in Mexico. Portal hypertension surgery as an example. Arch Surg (1997) 0.75

[Intrahepatic shunting in portal hypertension]. Rev Invest Clin (1986) 0.75

Postoperative portal vein obstruction in patients with idiopathic portal hypertension. J Clin Gastroenterol (1990) 0.75

[Science vs. technology vs. marketing: the case of video-assisted endoscopic surgery]. Rev Gastroenterol Mex (1994) 0.75

Investigation of the portal perfusion index after low diameter mesocaval interposition and distal splenorenal shunt--a prospective study. Surg Endosc (1991) 0.75

[Homage to Dr. Héctor Orozco Zepeda]. Rev Gastroenterol Mex (1999) 0.75

Surgical procedures for bleeding esophagogastric varices when sclerotherapy fails: a prospective study. Am J Surg (1990) 0.75

[Prolonged vascular access for hematological treatments: experience in the city of Puebla]. Rev Invest Clin (1988) 0.75

[Undifferentiated (embryonal) sarcoma of the liver. Report of a case]. Rev Invest Clin (1992) 0.75

100 meso-caval interposition-shunts for recurrent variceal hemorrhage in portal hypertension. A prospective study. Rev Invest Clin (1990) 0.75

[The liver transplant]. Rev Gastroenterol Mex (1993) 0.75

Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients. Transplant Proc (1996) 0.75

[Idiopathic portal hypertension]. Rev Invest Clin (1991) 0.75

[Primary lipoma of the liver]. Rev Gastroenterol Mex (2001) 0.75

[A comparative study of complications after vagotomy-pyloroplasty using Sugiura-Futagawa procedure and surgery of acid peptic disease]. Rev Gastroenterol Mex (1997) 0.75

[Elective-selective Warren splenorenal shunt operation. Prognosis of liver function and esophageal varices hemorrhage after repeat sclerotherapy in liver cirrhosis]. Chirurg (1991) 0.75